Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: results from a randomized clinical trial
Diaz, Ricardo Sobhie, Shytaj, Iart Luca, Giron, Leila B, Obermaier, Benedikt, Libera, Ermelindo della, Galinskas, Juliana, Dias, Danilo, Hunter, James, Janini, Mario, Gosuen, Gisele, Ferreira, Paulo ALanguage:
english
Journal:
International Journal of Antimicrobial Agents
DOI:
10.1016/j.ijantimicag.2019.08.001
Date:
August, 2019
File:
PDF, 748 KB
english, 2019